Items where authors include "Saha, V"

Article

Eckert, C, Parker, C orcid.org/0000-0002-3826-2554, Moorman, AV et al. (16 more authors) (2021) Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials. European Journal of Cancer, 151. pp. 175-189. ISSN 0959-8049

Parker, C orcid.org/0000-0002-3826-2554, Krishnan, S, Hamadeh, L et al. (8 more authors) (2019) Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial. The Lancet Haematology, 6 (4). E204-E216. ISSN 2352-3026

Johnson, SM, Dempsey, C, Parker, C orcid.org/0000-0002-3826-2554 et al. (3 more authors) (2017) Acute lymphoblastic leukaemia cells produce large extracellular vesicles containing organelles and an active cytoskeleton. JOURNAL OF EXTRACELLULAR VESICLES, 6 (1). 1294339. ISSN 2001-3078

Liu, J, Masurekar, A, Johnson, S et al. (13 more authors) (2015) Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia. Oncotarget, 6 (40). pp. 43048-43064. ISSN 1949-2553

Masurekar, AN, Parker, CA orcid.org/0000-0002-3826-2554, Shanyinde, M et al. (13 more authors) (2014) Outcome of Central Nervous System Relapses In Childhood Acute Lymphoblastic Leukaemia – Prospective Open Cohort Analyses of the ALLR3 Trial. PLoS ONE, 9 (10). e108107. ISSN 1932-6203

Masurekar, A, Fong, C, Hussain, A et al. (7 more authors) (2014) The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial. Blood Cancer Journal, 4. e203. ISSN 2044-5385

Krishnan, S, Wade, R, Moorman, AV et al. (7 more authors) (2010) Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985–2001. Leukemia, 24 (2). pp. 450-459. ISSN 0887-6924